- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04264520
Initial Intervention Efficacy for an Online PTSD Intervention for Pregnant Women
September 22, 2021 updated by: Mary Shapiro, Medical University of South Carolina
The current study aims to test a brief computer-assisted intervention (psychoeducation + skills) for pregnant women with elevated PTSD symptoms.
In this open trial pilot feasibility study, 20 pregnant women in their first trimester will be invited to participate in the study if they endorse elevated PTSD symptoms.
Oxytocin and cortisol will be measured at baseline, one month post-intervention, three months post-intervention, and post-delivery to inform the relationship between these hormones, PTSD symptoms, and peripartum/postpartum outcomes.
In addition to receiving the psychoeducation + skills intervention during their first trimester, women will be offered a "booster session" intervention following delivery to enhance utilization of skills during a critical period for maternal mental and physical health outcomes.
Study Overview
Status
Terminated
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
5
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina Institute of Psychiatry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- 18-40 years old
- Fluent in English
Exclusion Criteria:
- Active and severe domestic violence
- Evidence of a significant mental illness or current substance use disorder that would impede the completion of the intervention
- Suicidal individuals deemed at immediate danger or risk (i.e., requiring immediate hospitalization or treatment)
- Women who smoke
- Women who have a metabolic or endocrine disorder.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: PTSD Psychoeducation + Skills Intervention
|
A brief computer-assisted intervention (psychoeducation + skills) for pregnant women with elevated PTSD symptoms.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PTSD Checklist for DSM-5 (PCL-5) Total Scores
Time Frame: Baseline to follow-up (follow-up will occur at one-month following the baby's birth)
|
The PCL-5 is a 17-item self-report questionnaire designed to assess PTSD symptoms among civilians.
In the current study, PCL-5 total scores will be utilized.
Specifically, we will examine the impact of the intervention on change in PCL-5 scores across time (i.e., from baseline to post-delivery follow-up).
Scores on the PCL-5 range from 0 to 80, with higher scores indicating more symptoms.
|
Baseline to follow-up (follow-up will occur at one-month following the baby's birth)
|
Baby's Weight at Birth in Pounds/Ounces
Time Frame: Baseline to birth of baby.
|
Each baby's weight (in pounds/ounces) will be derived from the online medical record following delivery.
This outcome will be used to determine the relationship between maternal PTSD symptoms (as indexed by the PCL-5 total scores--above) and infant weight at birth.
|
Baseline to birth of baby.
|
Total Gestation Length in Weeks
Time Frame: Baseline to birth of baby.
|
The total gestation length, in weeks, will be derived from the online medical record following the baby's birth.
This outcome will be used to determine the relationship between maternal PTSD symptoms (as indexed by the PCL-5 total scores--above) and total weeks gestation at birth.
|
Baseline to birth of baby.
|
Baby's APGAR Score at Birth
Time Frame: Baseline to birth of baby.
|
Each baby's APGAR score will be derived from the online medical record following delivery.
APGAR scores range from 0-10, with higher scores indicating better health at birth for baby.
APGAR scores will be used to determine the relationship between maternal PTSD symptoms (as indexed by the PCL-5 total scores--above) and infant health at birth.
|
Baseline to birth of baby.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 5, 2020
Primary Completion (Actual)
April 23, 2021
Study Completion (Actual)
April 23, 2021
Study Registration Dates
First Submitted
February 3, 2020
First Submitted That Met QC Criteria
February 8, 2020
First Posted (Actual)
February 11, 2020
Study Record Updates
Last Update Posted (Actual)
September 28, 2021
Last Update Submitted That Met QC Criteria
September 22, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00096405
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Partum Depression
-
Washington University School of MedicineNurses for Newborns FoundationCompletedPost-partum DepressionUnited States
-
NYU Langone HealthWithdrawn
-
Curio Digital Therapeutics, Inc.RecruitingPost-partum DepressionUnited States
-
The University of Hong KongHospital Authority, Hong Kong; Kwong Wah HospitalCompleted
-
Children's Hospital of PhiladelphiaNational Institute of Mental Health (NIMH)Recruiting
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Not yet recruitingPost-partum DepressionItaly
-
University of RochesterNational Institute of Mental Health (NIMH)Recruiting
-
Federal University of PelotasCompletedPrematurity | Gestational Hypertension | Maternal Post-partum Depression | Maternal Post-partum Weight Retention | Child's DevelopmentBrazil
-
Johns Hopkins Bloomberg School of Public HealthNational Institute on Drug Abuse (NIDA)CompletedDepression | Substance Abuse | Post-partum DepressionUnited States
Clinical Trials on PTSD Psychoeducation + Skills Intervention
-
ŞİRİN HARKİNEnrolling by invitationSchizophrenia | Well-being | Caregiver | Psychoeducation | Communication SkillsTurkey
-
VA Office of Research and DevelopmentRecruiting
-
University of CalgaryUniversity of California, San Diego; The Zucker Hillside HospitalCompletedAt Risk of PsychosisCanada
-
Vanderbilt UniversitySan Diego State UniversityCompleted
-
Sunnybrook Health Sciences CentreTerminated
-
VA Office of Research and DevelopmentCompleted
-
Florida State UniversityMary Oglesby ShapiroCompletedAnxiety | Intolerance of UncertaintyUnited States
-
Chinese University of Hong KongCompleted
-
The University of Hong KongUniversity Grants Committee, Hong KongNot yet recruiting
-
Durham VA Medical CenterCompletedInsomnia | Posttraumatic Stress DisorderUnited States